AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80%Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
| ABX | ||
| 2,674.880 | ||
| -57.3440 | -0.0210% | |
| BISNIS-27 | ||
| 460.953 | ||
| -8.6940 | -0.0185% | |
| DBX | ||
| 3,619.315 | ||
| -71.1830 | -0.0193% | |
| ECONOMIC30 | ||
| 93.101 | ||
| -2.2020 | -0.0231% | |
| ESGQKEHATI | ||
| 110.293 | ||
| -2.1980 | -0.0195% | |
| ESGSKEHATI | ||
| 111.426 | ||
| -2.1640 | -0.0191% | |
| I-GRADE | ||
| 170.248 | ||
| -4.1980 | -0.0241% | |
| AUDRP | ||
| 12,464.750 | ||
| 1.1400 | 0.0091% | |
| EURRP | ||
| 20,336.810 | ||
| 14.2300 | 0.0700% | |
| JPYRP | ||
| 110.785 | ||
| 0.1741 | 0.1574% | |
| SINRP | ||
| 13,610.590 | ||
| 12.7600 | 0.0938% | |
| USDRP | ||
| 17,329.000 | ||
| 4.0000 | 0.0231% | |
